Strategic Partnerships Mediprocity has a history of integrating with LTC software providers and pharmacy management systems (e.g., SuiteRx, RedSail DocuTrack, SoftWriters). This suggests a growth opportunity through co-sell or referral agreements with established LTC IT vendors to expand reach into pharmacies, facilities, and prescribers.

Integrated Communications There is strong potential to upsell to healthcare networks by highlighting secure messaging, forms, mobile Rx orders, and narcotic count tools as a unified communications platform that reduces operating costs and improves patient/resident care outcomes, especially for LTC, hospice, home health, and skilled nursing facilities.

Compliance Advantage HIPAA-compliant secure communications position Mediprocity well for clinics and facilities expanding regulatory scrutiny. Target prospects prioritizing data security, audit trails, and compliant e-prescribing in regulated environments.

Growth Signals Recent integration into SuiteRx in 2026 indicates active expansion and momentum. This can be leveraged to approach customers of SuiteRx and other partner ecosystems with joint marketing and bundled solutions.

Financial Opportunity With a revenue range of 1M-10M and a lean team (11-50 employees), Mediprocity appears to be in an accelerator phase suitable for rapid expand-through-channel and SMB-to-mid-market sales motions, including scalable pricing and pilot programs.